Khattar Jack A.'s Form 4 filing
Supernus Pharmaceuticals, Inc. (SUPN) · filed Oct 10, 2025
- Accession no.
- 0001628280-25-044830
- Filed
- Oct 10, 2025
- Trade date
- Oct 9, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.03M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Khattar Jack A.CIK 0001539937 | Director, Officer (President, CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | Common Stock | MOption exerciseAcquired | +81,250 | $25.30 | +$2,055,625 | 1,266,478 | Direct | |
| Oct 9, 2025 | Common Stock | SSaleDisposed | −58,371 | $50.55 | −$2,950,654.05 | 1,208,107 | Direct | |
| Oct 9, 2025 | Common Stock | SSaleDisposed | −1,529 | $51.46 | −$78,682.34 | 1,206,578 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | Common Stock | MOption exerciseDisposed | −81,250 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.